Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Hui Hoo

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Evaluation in Clinical Practice|January 26, 2019
Understanding FEV<sub>1</sub> for the purpose of cystic fibrosis registry comparisons: Does bias in annual review FEV<sub>1</sub> affect between-centre comparison within the UK? An analysis of registry dataZhe Hui Hoo, Michael J Campbell, Stephen J Walters, et al.
F1000Research|November 27, 2018
Using different methods to process forced expiratory volume in one second (FEV <sub>1</sub>) data can impact on the interpretation of FEV <sub>1</sub> as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart reviewZhe Hui Hoo, Muhaned S A El-Gheryani, Rachael Curley, et al.
Patient Preference and Adherence|March 14, 2019
A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosisZhe Hui Hoo, Martin J Wildman, Michael J Campbell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2017
Do cystic fibrosis centres with the lowest FEV<sub>1</sub> still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UKZhe Hui Hoo, Michael J Campbell, Rachael Curley, et al.
Respirology (Carlton, Vic.)|September 15, 2017
Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CFZhe Hui Hoo, Martin J Wildman, Rachael Curley, et al.
Journal of Evaluation in Clinical Practice|June 15, 2018
The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV<sub>1</sub> in the UK only collected when subjects are well?Zhe Hui Hoo, Rachael Curley, Michael J Campbell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 4, 2019
Exploring the implications of different approaches to estimate centre-level adherence using objective adherence data in an adult cystic fibrosis centre - a retrospective observational studyZhe Hui Hoo, Rachael Curley, Stephen J Walters, et al.
Patient Preference and Adherence|June 11, 2016
Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence"Zhe Hui Hoo, Rachael Curley, Michael J Campbell, et al.
Patient Preference and Adherence|September 9, 2015
Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherenceStephen Jones, Nathan Babiker, Emma Gardner, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 8, 2024
Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy - a multi-center observational study within the CFHealthHub learning health systemRobert D Sandler, Lana Lai, Sophie Dawson, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Evaluation in Clinical Practice|January 26, 2019
Understanding FEV<sub>1</sub> for the purpose of cystic fibrosis registry comparisons: Does bias in annual review FEV<sub>1</sub> affect between-centre comparison within the UK? An analysis of registry dataZhe Hui Hoo, Michael J Campbell, Stephen J Walters, et al.
F1000Research|November 27, 2018
Using different methods to process forced expiratory volume in one second (FEV <sub>1</sub>) data can impact on the interpretation of FEV <sub>1</sub> as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart reviewZhe Hui Hoo, Muhaned S A El-Gheryani, Rachael Curley, et al.
Patient Preference and Adherence|March 14, 2019
A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosisZhe Hui Hoo, Martin J Wildman, Michael J Campbell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2017
Do cystic fibrosis centres with the lowest FEV<sub>1</sub> still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UKZhe Hui Hoo, Michael J Campbell, Rachael Curley, et al.
Respirology (Carlton, Vic.)|September 15, 2017
Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CFZhe Hui Hoo, Martin J Wildman, Rachael Curley, et al.
Journal of Evaluation in Clinical Practice|June 15, 2018
The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV<sub>1</sub> in the UK only collected when subjects are well?Zhe Hui Hoo, Rachael Curley, Michael J Campbell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 4, 2019
Exploring the implications of different approaches to estimate centre-level adherence using objective adherence data in an adult cystic fibrosis centre - a retrospective observational studyZhe Hui Hoo, Rachael Curley, Stephen J Walters, et al.
Patient Preference and Adherence|June 11, 2016
Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence"Zhe Hui Hoo, Rachael Curley, Michael J Campbell, et al.
Patient Preference and Adherence|September 9, 2015
Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherenceStephen Jones, Nathan Babiker, Emma Gardner, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 8, 2024
Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy - a multi-center observational study within the CFHealthHub learning health systemRobert D Sandler, Lana Lai, Sophie Dawson, et al.
Pageof 3